Convergent Finance LLP announced that it is investing up to $23.8 million (INR 180 crore) in Camlin Fine Sciences Limited.

Camlin Fine Sciences Limited is a Mumbai-based company that manufactures antioxidants and aroma chemicals supplied to the food industry globally.

The company is focused on providing– shelf-life solutions, aroma ingredients, health & wellness, and performance chemicals. 

Coming back to the investment, Convergent Finance, through its entity Infinity Investment Management, will pick up approximately 22.65% stake in Camlin Fine Sciences.

Talking about this investment and the partnership, Ashish Dandekar, MD of Camlin, said,

“Given our M&A oriented strategy, this investment and the partnership that it brings with Convergent will enable us to leverage Convergent’s deep global expertise and relationships while benefiting from their strategic guidance.”